Mostrar el registro sencillo del ítem

dc.contributor.authorSerna-Galvis, Efraim A.
dc.contributor.authorIsaza-Pineda, Laura
dc.contributor.authorMoncayo-Lasso, Alejandro
dc.contributor.authorHernandez, Felix
dc.contributor.authorIbáñez, Maria
dc.contributor.authorTorres-Palma, Ricardo A.
dc.date.accessioned2019-10-01T15:41:34Z
dc.date.available2019-10-01T15:41:34Z
dc.date.issued2019
dc.identifier.citationSERNA-GALVIS, Efraim A., et al. Comparative degradation of two highly consumed antihypertensives in water by sonochemical process. Determination of the reaction zone, primary degradation products and theoretical calculations on the oxidative process. Ultrasonics Sonochemistry, 2019, p. 104635ca_CA
dc.identifier.issn1350-4177
dc.identifier.issn1873-2828
dc.identifier.urihttp://hdl.handle.net/10234/184035
dc.description.abstractThis work compares the sonochemical degradation of losartan and valsartan (antihypertensives) in water. Initially, the suitable operational conditions of ultrasonic power density and frequency were established. Under such conditions, losartan was eliminated in a higher percentage than valsartan, which was associated to differences in their hydrophobicities. Additionally, degradations in presence of isopropanol and ferrous ions confirmed that losartan was closer to cavitation bubble than valsartan. The structures of primary products indicated that sonogenerated hydroxyl radical attacked biphenyl tetrazole moiety (common nucleus of both pharmaceuticals). Then, theoretical calculations were applied to the products to estimate the toxicity, degree of oxidation and probable routes of aerobic biodegradation suggesting a beneficial action of sonodegradation. Finally, the sonochemical degradation of the antihypertensives was carried out in two simulated complex matrices (i.e., seawater and hospital wastewater) and an actual wastewater. Interestingly, the losartan and valsartan eliminations in such waters were similar to the observed in distilled water. This fact indicates the high potentiality of ultrasound to degrade losartan or valsartan in waters containing other substances, even at higher concentrations than these pollutants.ca_CA
dc.format.extent11 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherElsevierca_CA
dc.relation.isPartOfUltrasonics Sonochemistry, 2019, p. 104635ca_CA
dc.rights© 2019 Elsevier B.V. All rights reserved.ca_CA
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/*
dc.subjectlosartanca_CA
dc.subjectvalsartanca_CA
dc.subjectadvanced oxidation processca_CA
dc.subjecthigh frequency ultrasoundca_CA
dc.subjectwater treatmentca_CA
dc.subjectpollutants eliminationca_CA
dc.titleComparative degradation of two highly consumed antihypertensives in water by sonochemical process. Determination of the reaction zone, primary degradation products and theoretical calculations on the oxidative processca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1016/j.ultsonch.2019.104635
dc.relation.projectIDheauthorsthankUniversidaddeAntioquiaUdeAforthesupportprovidedtotheirresearchgroupthrough“ProgramadeSostenibilidad”and the financing from COLCIENCIAS through the projects No.111577757323 (Convocatoria 777 de 2017) and No. 123371552034(Convocatoria 715 de 2015). The authors from UJI acknowledge thefinancial support from Generalitat Valenciana (Research Group ofExcellence, PrometeoII/2014/023). The authors from UniversidadAntonio Nariño acknowledge the funding from UAN (Colombia)throughtheprojectNo.2018208.E.A.Serna-GalvisthanksthedoctoralscholarshipfromCOLCIENCIAS(Convocatoria647de2014)ca_CA
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttps://www.sciencedirect.com/science/article/pii/S1350417719303979ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem